Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 714.00
+8.35 (1.18%)
Mar 10, 2026, 3:29 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 138.7 billion as of March 10, 2026. Its market cap has decreased by -13.75% in one year.
Market Cap
138.70B
Enterprise Value
152.13B
Revenue
72.67B
Ranking
n/a
PE Ratio
22.01
Stock Price
714.00
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 138.70B, an increase of 1,440.88%. That is a compound annual growth rate of 20.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 138.70B | -16.60% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 288.38B |
| Gland Pharma | 276.38B |
| Wockhardt | 206.24B |
| Piramal Pharma | 201.04B |
| Eris Lifesciences | 184.01B |
| NATCO Pharma | 179.59B |
| Alivus Life Sciences | 112.89B |
| Cohance Lifesciences | 108.09B |